Long-term risk of adverse outcomes according to atrial fibrillation type.

Details

Ressource 1Download: 35140237_BIB_5715BFE6EA8D.pdf (1036.88 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_5715BFE6EA8D
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Long-term risk of adverse outcomes according to atrial fibrillation type.
Journal
Scientific reports
Author(s)
Blum S., Aeschbacher S., Coslovsky M., Meyre P.B., Reddiess P., Ammann P., Erne P., Moschovitis G., Di Valentino M., Shah D., Schläpfer J., Müller R., Beer J.H., Kobza R., Bonati L.H., Moutzouri E., Rodondi N., Meyer-Zürn C., Kühne M., Sticherling C., Osswald S., Conen D.
Working group(s)
BEAT-AF and Swiss-AF investigators
Contributor(s)
Aeschbacher S., Auberson C., Blum S., Bonati L., Ceylan S., Conen D., Evers-Doerpfeld S., Eken C., Girod M., Hennings E., Herber E., Iten V., Krisai P., Lampart M., Lischer M., Meyer-Zürn C., Meyre P., Monsch A.U., Müller C., Paladini R.E., Springer A., Sticherling C., Szucs T., Völlmin G., Osswald S., Kühne M., Aujesky D., Fischer U., Fuhrer J., Roten L., Jung S., Mattle H., Netzer S., Adam L., Aubert C.E., Feller M., Loewe A., Moutzouri E., Schneider C., Flückiger T., Groen C., Ehrsam L., Hellrigl S., Nuoffer A., Rakovic D., Schwab N., Wenger R., Saffari THZ, Rodondi N., Reichlin T., Beynon C., Dillier R., Deubelbeiss M., Eberli F., Franzini C., Juchli I., Liedtke C., Murugiah S., Nadler J., Obst T., Roth J., Schlomowitsch F., Schneider X., Studerus K., Tynan N., Weishaupt D., Müller A., Fontana S., Friedli C., Kuest S., Scheuch K., Hischier D., Bonetti N., Grau A., Villinger J., Laube E., Baumgartner P., Filipovic M., Frick M., Montrasio G., Leuenberger S., Rutz F., Beer J.H., Auricchio A., Anesini A., Camporini C., Conte G., Caputo M.L., Regoli F., Moccetti T., Brenner R., Altmann D., Gemperle M., Ammann P., Firmann M., Foucras S., Rime M., Hayoz D., Berte B., Justi V., Kellner-Weldon F., Mehmann B., Meier S., Roth M., Ruckli-Kaeppeli A., Russi I., Schmidt K., Young M., Zbinden M., Kobza R., Rigamonti E., Cereda C., Cianfoni A., De Perna M.L., Frangi-Kultalahti J., Melchiorre PAM, Pin A., Terrot T., Vicari L., Moschovitis G., Ehret G., Gallet H., Guillermet E., Lazeyras F., Lovblad K.O., Perret P., Tavel P., Teres C., Shah D., Lauriers N., Méan M., Salzmann S., Schläpfer J., Porretta A.P., Grêt A., Novak J., Vitelli S., Stephan F.P., Frangi-Kultalahti J., Gallino A., Vicari L., Di Valentino M., Aebersold H., Foster F., Schwenkglenks M., Würfel J., Altermatt A., Amann M., Düring M., Huber P., Ruberte E., Sinnecker T., Zuber V., Coslovsky M., Benkert P., Dutilh G., Markovic M., Neuschwander P., Simon P., Schmid R.
ISSN
2045-2322 (Electronic)
ISSN-L
2045-2322
Publication state
Published
Issued date
09/02/2022
Peer-reviewed
Oui
Volume
12
Number
1
Pages
2208
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Abstract
Sustained forms of atrial fibrillation (AF) may be associated with a higher risk of adverse outcomes, but few if any long-term studies took into account changes of AF type and co-morbidities over time. We prospectively followed 3843 AF patients and collected information on AF type and co-morbidities during yearly follow-ups. The primary outcome was a composite of stroke or systemic embolism (SE). Secondary outcomes included myocardial infarction, hospitalization for congestive heart failure (CHF), bleeding and all-cause mortality. Multivariable adjusted Cox proportional hazards models with time-varying covariates were used to compare hazard ratios (HR) according to AF type. At baseline 1895 (49%), 1046 (27%) and 902 (24%) patients had paroxysmal, persistent and permanent AF and 3234 (84%) were anticoagulated. After a median (IQR) follow-up of 3.0 (1.9; 4.2) years, the incidence of stroke/SE was 1.0 per 100 patient-years. The incidence of myocardial infarction, CHF, bleeding and all-cause mortality was 0.7, 3.0, 2.9 and 2.7 per 100 patient-years, respectively. The multivariable adjusted (a) HRs (95% confidence interval) for stroke/SE were 1.13 (0.69; 1.85) and 1.27 (0.83; 1.95) for time-updated persistent and permanent AF, respectively. The corresponding aHRs were 1.23 (0.89, 1.69) and 1.45 (1.12; 1.87) for all-cause mortality, 1.34 (1.00; 1.80) and 1.30 (1.01; 1.67) for CHF, 0.91 (0.48; 1.72) and 0.95 (0.56; 1.59) for myocardial infarction, and 0.89 (0.70; 1.14) and 1.00 (0.81; 1.24) for bleeding. In this large prospective cohort of AF patients, time-updated AF type was not associated with incident stroke/SE.
Keywords
Aged, Aged, 80 and over, Atrial Fibrillation/complications, Atrial Fibrillation/epidemiology, Atrial Fibrillation/mortality, Cause of Death, Cohort Studies, Comorbidity, Embolism/complications, Embolism/epidemiology, Female, Follow-Up Studies, Heart Failure/complications, Heart Failure/epidemiology, Hemorrhage/complications, Hemorrhage/epidemiology, Hospitalization/statistics & numerical data, Humans, Incidence, Male, Middle Aged, Myocardial Infarction/complications, Myocardial Infarction/epidemiology, Proportional Hazards Models, Prospective Studies, Risk Factors, Stroke/complications, Stroke/epidemiology, Switzerland/epidemiology
Pubmed
Web of science
Open Access
Yes
Create date
19/02/2022 12:58
Last modification date
23/01/2024 8:25
Usage data